KLF4 expression in the cancer group is significantly higher than that in the control group, and the positive rate of stage II, III and IV is higher than that of stage I. Its expression is independent of age and sex of patients, and is a potential biomarker in late stage of SCLC [63]. This evidence concerns the gene KLF4 and small cell lung carcinoma.